1014 related articles for article (PubMed ID: 23471038)
1. In vitro inhibition of Clostridium difficile and Clostridium perfringens by commercial probiotic strains.
Schoster A; Kokotovic B; Permin A; Pedersen PD; Dal Bello F; Guardabassi L
Anaerobe; 2013 Apr; 20():36-41. PubMed ID: 23471038
[TBL] [Abstract][Full Text] [Related]
2. In vitro inhibition of Clostridium difficile by commercial probiotics: A microcalorimetric study.
Fredua-Agyeman M; Stapleton P; Basit AW; Beezer AE; Gaisford S
Int J Pharm; 2017 Jan; 517(1-2):96-103. PubMed ID: 27923699
[TBL] [Abstract][Full Text] [Related]
3. In Vitro Antimicrobial Activity and Probiotic Potential of
Monteiro CRAV; do Carmo MS; Melo BO; Alves MS; Dos Santos CI; Monteiro SG; Bomfim MRQ; Fernandes ES; Monteiro-Neto V
Nutrients; 2019 Feb; 11(2):. PubMed ID: 30795551
[TBL] [Abstract][Full Text] [Related]
4. Prebiotic-non-digestible oligosaccharides preference of probiotic bifidobacteria and antimicrobial activity against Clostridium difficile.
Kondepudi KK; Ambalam P; Nilsson I; Wadström T; Ljungh A
Anaerobe; 2012 Oct; 18(5):489-97. PubMed ID: 22940065
[TBL] [Abstract][Full Text] [Related]
5. Antagonistic activity of probiotic lactobacilli and bifidobacteria against entero- and uropathogens.
Hütt P; Shchepetova J; Lõivukene K; Kullisaar T; Mikelsaar M
J Appl Microbiol; 2006 Jun; 100(6):1324-32. PubMed ID: 16696680
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of Clostridium difficile growth and adhesion to enterocytes by Bifidobacterium supernatants.
Trejo FM; Minnaard J; Perez PF; De Antoni GL
Anaerobe; 2006 Aug; 12(4):186-93. PubMed ID: 16759886
[TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo antagonistic activity of new probiotic culture against Clostridium difficile and Clostridium perfringens.
Golić N; Veljović K; Popović N; Djokić J; Strahinić I; Mrvaljević I; Terzić-Vidojević A
BMC Microbiol; 2017 May; 17(1):108. PubMed ID: 28477627
[TBL] [Abstract][Full Text] [Related]
8. In vitro evaluation of the antimicrobial activity of a range of probiotics against pathogens: evidence for the effects of organic acids.
Tejero-Sariñena S; Barlow J; Costabile A; Gibson GR; Rowland I
Anaerobe; 2012 Oct; 18(5):530-8. PubMed ID: 22959627
[TBL] [Abstract][Full Text] [Related]
9. Commercial probiotic cell-free supernatants for inhibition of Clostridium perfringens poultry meat infection in Egypt.
Hamad GM; Abdelmotilib NM; Darwish AMG; Zeitoun AM
Anaerobe; 2020 Apr; 62():102181. PubMed ID: 32092413
[TBL] [Abstract][Full Text] [Related]
10. In vitro evaluation of single- and multi-strain probiotics: Inter-species inhibition between probiotic strains, and inhibition of pathogens.
Chapman CM; Gibson GR; Rowland I
Anaerobe; 2012 Aug; 18(4):405-13. PubMed ID: 22677262
[TBL] [Abstract][Full Text] [Related]
11. Prebiotic preferences of human lactobacilli strains in co-culture with bifidobacteria and antimicrobial activity against Clostridium difficile.
Ambalam P; Kondepudi KK; Balusupati P; Nilsson I; Wadström T; Ljungh Å
J Appl Microbiol; 2015 Dec; 119(6):1672-82. PubMed ID: 26381324
[TBL] [Abstract][Full Text] [Related]
12. Probiotic properties of Lactobacillus and Bifidobacterium strains isolated from porcine gastrointestinal tract.
Kim PI; Jung MY; Chang YH; Kim S; Kim SJ; Park YH
Appl Microbiol Biotechnol; 2007 Apr; 74(5):1103-11. PubMed ID: 17136367
[TBL] [Abstract][Full Text] [Related]
13. A combination of the probiotic and prebiotic product can prevent the germination of Clostridium difficile spores and infection.
Rätsep M; Kõljalg S; Sepp E; Smidt I; Truusalu K; Songisepp E; Stsepetova J; Naaber P; Mikelsaar RH; Mikelsaar M
Anaerobe; 2017 Oct; 47():94-103. PubMed ID: 28465256
[TBL] [Abstract][Full Text] [Related]
14. Assessment of the in vitro inhibitory activity of specific probiotic bacteria against different Escherichia coli strains.
Mogna L; Del Piano M; Deidda F; Nicola S; Soattini L; Debiaggi R; Sforza F; Strozzi G; Mogna G
J Clin Gastroenterol; 2012 Oct; 46 Suppl():S29-32. PubMed ID: 22955353
[TBL] [Abstract][Full Text] [Related]
15. Antibiotic susceptibility profiles of new probiotic Lactobacillus and Bifidobacterium strains.
Zhou JS; Pillidge CJ; Gopal PK; Gill HS
Int J Food Microbiol; 2005 Feb; 98(2):211-7. PubMed ID: 15681048
[TBL] [Abstract][Full Text] [Related]
16. Subtractive screening for probiotic properties of lactobacillus species from the human gastrointestinal tract in the search for new probiotics.
Delgado S; O'Sullivan E; Fitzgerald G; Mayo B
J Food Sci; 2007 Oct; 72(8):M310-5. PubMed ID: 17995611
[TBL] [Abstract][Full Text] [Related]
17. Effect of a probiotic on prevention of diarrhea and Clostridium difficile and Clostridium perfringens shedding in foals.
Schoster A; Staempfli HR; Abrahams M; Jalali M; Weese JS; Guardabassi L
J Vet Intern Med; 2015; 29(3):925-31. PubMed ID: 25903509
[TBL] [Abstract][Full Text] [Related]
18. In vitro activity of potential probiotic Lactobacillus murinus isolated from the dog.
Perelmuter K; Fraga M; Zunino P
J Appl Microbiol; 2008 Jun; 104(6):1718-25. PubMed ID: 18194243
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the probiotic properties of new Lactobacillus and Bifidobacterium strains and their in vitro effect.
Presti I; D'Orazio G; Labra M; La Ferla B; Mezzasalma V; Bizzaro G; Giardina S; Michelotti A; Tursi F; Vassallo M; Di Gennaro P
Appl Microbiol Biotechnol; 2015 Jul; 99(13):5613-26. PubMed ID: 25744647
[TBL] [Abstract][Full Text] [Related]
20. Co-culture with potentially probiotic microorganisms antagonises virulence factors of Clostridium difficile in vitro.
Trejo FM; Pérez PF; De Antoni GL
Antonie Van Leeuwenhoek; 2010 Jun; 98(1):19-29. PubMed ID: 20232250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
